Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone ...

A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer ...

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...

Clinical Features. Basal cell carcinoma (BCC) is the most common malignant eyelid tumor, accounting for 85% of all such tumors. [1] The tumor usually affects adults but may also occur in younger ...

Imiquimod: Stimulates the immune system to help eliminate the wart. Retinoids: Vitamin A-derived medications that can be effective in some cases. Diphencyprone and Podophyllin: Compounds used in ...

Molluscum contagiosum is an infection that causes small bumps on the skin and can be spread through contact with a virus. Though it often heals on its own, several treatment options are also ...